2016
DOI: 10.1194/jlr.m061978
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
46
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 65 publications
(53 citation statements)
references
References 24 publications
5
46
2
Order By: Relevance
“…Considering that the specificity of the oxysterol analysis for NPC diagnosis is not fully understood, since oxysterol elevation could also occur in other conditions with high oxidative stress or cholesterol accumulation [18,19,34], the aim of this work was to investigate the potential use of the 3β,5α,6β-triol analysis in the screening of non-newborn patients with clinical suspicion of NPC, correlating the measurements with the results of Filipin test, chitotriosidase activity and molecular analysis. Our data showed that all not-treated patients with positive results in the Filipin test also presented high concentrations of 3β,5α,6β-triol (higher than 100 ng/mL), indicating that the 3β,5α,6β-triol measurement was effective in detecting NPC patients.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering that the specificity of the oxysterol analysis for NPC diagnosis is not fully understood, since oxysterol elevation could also occur in other conditions with high oxidative stress or cholesterol accumulation [18,19,34], the aim of this work was to investigate the potential use of the 3β,5α,6β-triol analysis in the screening of non-newborn patients with clinical suspicion of NPC, correlating the measurements with the results of Filipin test, chitotriosidase activity and molecular analysis. Our data showed that all not-treated patients with positive results in the Filipin test also presented high concentrations of 3β,5α,6β-triol (higher than 100 ng/mL), indicating that the 3β,5α,6β-triol measurement was effective in detecting NPC patients.…”
Section: Discussionmentioning
confidence: 99%
“…Emerging evidence suggest that cholesterol oxidation products, specially 7-ketocholesterol (7-KC) and cholestane-3β,5α,6β-triol (3β,5α,6β-triol, or triol), are markedly increased in the plasma of NPC patients, indicating that these products could be used as non-invasive and highly sensitive biomarkers for NPC disease [17][18][19]. These oxysterols are products of non-enzymatic cholesterol oxidation due to an increased oxidative stress process, which was reported in human NPC mutant fibroblasts, in tissues from NPC1 mutant mice and in biological samples from affected patients [20][21][22].…”
Section: Introductionmentioning
confidence: 99%
“…NPC can also present challenges to diagnosis due to its wide variability in terms of clinical severity and the age at onset. Laboratory testing options have been limited; promising biomarkers like oxysterols have some shortcomings: they are sensitive to autoxidation, and not very specific because they are increased in neonatal cholestasis [3], in NPA/B and in other cholesterol defects [19][20][21]. The Lyso forms of sphingosine, LysoSM and LysoSM-509, markers of NPA/B, were also increased in NPC, confirming their diagnostic potential for the diagnosis of NPC.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, increased levels of 7KC have been reported in the plasma and/or the cerebrospinal fluid of patients with neurodegenerative diseases. Thus far, 7KC has been identified at increased levels in the cerebrospinal fluid of patients with MS [21] as well as in the plasma of patients with X-ALD [22] and Niemann–Pick disease [23]. 7KC has also been detected at higher levels in the plasma of patients with the progressive form of MS than in plasma from patients with the relapsing remitting form of MS [24].…”
Section: Introductionmentioning
confidence: 99%